We found that the percentage of CD14+HLA-DR−/low MDSCs in the paracancer liver tissue of CRLM patients (n = 20) was higher than the hepatic hemangioma patients (n = 6) (3.4% ± 2.3% vs. 1.1% ± 0.5%, P = 0.032) (Fig. 7a). This evidence concerns the gene CD14 and liver hemangioma.